Article

OBJECTIVE: To identify psychometrically robust and clinically feasible measures
of walking and mobility in people with neurological conditions. DATA SOURCES:
MEDLINE, CINAHL, EMBASE, PEDro and AMED. REVIEW METHODS: Independent reviewers
selected and extracted data from articles that assessed the reliability,
validity, sensitivity to change or clinical utility of measures of walking and
mobility in adult neurological conditions. Measures with 'good' psychometrics and
9/10 clinical utility scores were recommended. RESULTS: Seventeen measures were
selected. Of these, the 5-m and 10-m walk tests, six-minute walk test, High Level
Mobility Assessment Tool (HiMAT) and the Rivermead Mobility Index (RMI) reached
the required standards and are usable in clinical practice.
None of the
recommended measures assessed wheelchair mobility. The least frequently assessed
property was sensitivity to change. Further measures could be recommended if the
minimal detectable change were demonstrated.
CONCLUSION: The 5-m, 10-m and six-minute walk test, High Level Mobility Assessment Tool and the Rivermead
Mobility Index are psychometrically robust measures of walking and mobility and
are feasible for use in clinical practice.

Langue : ANGLAIS